These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3663816)

  • 1. The analysis of cancer chemoprevention experiments.
    Kokoska SM
    Biometrics; 1987 Sep; 43(3):525-34. PubMed ID: 3663816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The statistical analysis of cancer inhibition/promotion experiments.
    Kokoska SM; Hardin JM; Grubbs CJ; Hsu C
    Anticancer Res; 1993; 13(5A):1357-63. PubMed ID: 8239506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer.
    Shealy YF; Frye JL; Riordan JM; Hill DL; McPhillips M; Wille JJ; Sani BP; Kalin JR; Eto I; Grubbs CJ
    Anticancer Drug Des; 1997 Jan; 12(1):15-33. PubMed ID: 9051111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis of animal cancer chemoprevention experiments.
    Freedman LS; Midthune DN; Brown CC; Steele V; Kelloff GJ
    Biometrics; 1993 Mar; 49(1):259-68. PubMed ID: 8513108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing effects on tumor multiplicity and growth rate in chemoprevention experiments.
    Dunson DB; Dinse GE
    Biometrics; 2000 Dec; 56(4):1068-75. PubMed ID: 11129462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computer program for the statistical analysis of cancer inhibition/promotion experiments.
    Kokoska S; Urlwin J
    Comput Methods Programs Biomed; 1990 Sep; 33(1):1-7. PubMed ID: 2261749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of comparative carcinogenesis experiments based on multiple times to tumor.
    Gail MH; Santner TJ; Brown CC
    Biometrics; 1980 Jun; 36(2):255-66. PubMed ID: 7407314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytostasis and cancer chemoprevention: investigating the action of triphenylselenonium chloride in in vivo models of mammary carcinogenesis.
    Ip C; Thompson HJ; Ganther HE
    Anticancer Res; 1998; 18(1A):9-12. PubMed ID: 9568048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat by the retinoid axerophthene.
    Thompson HJ; Becci PJ; Moon RC; Sporn MB; Newton DL; Brown CC; Nürrenbach A; Paust J
    Arzneimittelforschung; 1980; 30(7):1127-9. PubMed ID: 7191293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of retinyl acetate and melatonin on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. A preliminary report.
    Bojková B; Kubatka P; Môciková K; Mníchová M; Ahlersová E; Ahlers I
    Folia Biol (Praha); 2000; 46(2):73-6. PubMed ID: 10813094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats.
    Ahlersová E; Ahlers I; Kubatka P; Bojková B; Môciková K; Gajdosová S; Onderková HM
    Folia Biol (Praha); 2000; 46(2):69-72. PubMed ID: 10813093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA).
    Cohen LA; Amin S; Marks PA; Rifkind RA; Desai D; Richon VM
    Anticancer Res; 1999; 19(6B):4999-5005. PubMed ID: 10697502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention with triphenylselenonium chloride in selenium-deficient rats.
    Ip C; Lisk DJ; Ganther HE
    Anticancer Res; 2000; 20(6B):4179-82. PubMed ID: 11205245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats.
    Hakkak R; Korourian S; Shelnutt SR; Lensing S; Ronis MJ; Badger TM
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):113-7. PubMed ID: 10667471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group sequential procedures for repeated events data with frailty.
    Jiang W
    J Biopharm Stat; 1999 Aug; 9(3):379-99. PubMed ID: 10473027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.
    Ip C; Thompson HJ; Zhu Z; Ganther HE
    Cancer Res; 2000 Jun; 60(11):2882-6. PubMed ID: 10850432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis.
    Abrams TJ; Guzman RC; Swanson SM; Thordarson G; Talamantes F; Nandi S
    Anticancer Res; 1998; 18(6A):4115-21. PubMed ID: 9891455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
    Christov K; Grubbs CJ; Shilkaitis A; Juliana MM; Lubet RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5488-96. PubMed ID: 17875779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.